|
Re: Resverlogix Files 2017 Year-End Disclosure Documents and Announces Plans to Host a Symposium at the European Society of Cardiology Congress 2017
|
4
|
Resverlogix Corp.
|
Jul 25, 2017 09:47PM
|
|
Re: Resverlogix Files 2017 Year-End Disclosure Documents and Announces Plans to Host a Symposium at the European Society of Cardiology Congress 2017
|
2
|
Resverlogix Corp.
|
Jul 26, 2017 10:15AM
|
|
Re: RESVERLOGIX EXCEEDS FULL ENROLLMENT FOR THE PIVOTAL PHASE 3 BETONMACE CLINICAL TRIAL
|
3
|
Resverlogix Corp.
|
Mar 19, 2018 10:32AM
|
|
Re: Resverlogix Donates
|
2
|
Resverlogix Corp.
|
Feb 07, 2020 04:10PM
|
|
Re: Resverlogix Cognition Substudy of the BETonMACE Phase 3 Cardiovascular Trial Presented at the International AD/PD Conference
|
3
|
Resverlogix Corp.
|
Apr 01, 2019 01:34PM
|
|
Re: Resverlogix Closes US$30 Million Loan
|
5
|
Resverlogix Corp.
|
May 07, 2018 04:48PM
|
|
Re: Resverlogix Closes Extension of Maturity Date of Loan and Announces Private Placement
|
4
|
Resverlogix Corp.
|
Sep 05, 2017 12:25PM
|
|
Re: Resverlogix Closes Extension of Maturity Date of Loan and Announces Private Placement
|
1
|
Resverlogix Corp.
|
Sep 05, 2017 02:50PM
|
|
Re: Resverlogix Announces US$30 Million Loan Commitment Letter .
|
1
|
Resverlogix Corp.
|
Apr 11, 2018 10:19AM
|
|
Re: RESVERLOGIX ANNOUNCES PROPOSED OFFERING OF UNITS April 17, 2018
|
1
|
Resverlogix Corp.
|
May 14, 2019 08:57PM
|
|
Re: RESVERLOGIX ANNOUNCES PROPOSED OFFERING OF UNITS April 17, 2018
|
2
|
Resverlogix Corp.
|
May 14, 2019 09:43PM
|
|
Re: Resverlogix Announces Proposed Offering of Units
|
2
|
Resverlogix Corp.
|
Apr 17, 2018 10:16AM
|
|
Re: Resverlogix Announces Presentation at 9th Annual Biotech Showcase Conference in San Francisco, CA
|
1
|
Resverlogix Corp.
|
Jan 07, 2017 06:05PM
|
|
Re: Resverlogix Announces Participation in Upcoming Conferences
|
3
|
Resverlogix Corp.
|
Nov 02, 2017 12:12PM
|
|
Re: Resverlogix Announces Participation at the ACC/WCC Virtual Meeting
|
2
|
Resverlogix Corp.
|
Mar 31, 2020 10:01AM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
3
|
Resverlogix Corp.
|
Mar 11, 2019 10:10AM
|
|
Re: Resverlogix Announces Overnight Marketed Equity Offering
|
2
|
Resverlogix Corp.
|
Jun 08, 2017 05:21PM
|
|
Re: Resverlogix Announces Ninth Positive DSMB Recommendation for Phase 3 Study of Apabetalone
|
4
|
Resverlogix Corp.
|
Mar 27, 2019 12:48PM
|
|
Re: Resverlogix Announces FDA Confirmation Regarding Filing Pathway for Apabetalone
|
5
|
Resverlogix Corp.
|
Jun 15, 2018 03:51PM
|
|
Re: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
3
|
Resverlogix Corp.
|
Oct 14, 2020 04:41PM
|
